AP NEWS

Global Cervical Cancer Diagnostic Testing Market 2019-2023 | Increased Adoption of HPV Home Testing Kits to Boost Demand | Technavio

November 9, 2018

LONDON--(BUSINESS WIRE)--Nov 9, 2018-- analysts forecast the global cervical cancer diagnostic testing market to grow at a CAGR of over 6 % during the forecast period, according to their latest market research report. The growth momentum of the market is expected to accelerate in the year-over-year growth.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181109005270/en/

Technavio analysts forecast the global cervical cancer diagnostic testing market to grow at a CAGR of over 6% by 2023. (Graphic: Business Wire)

Rising incidence of cervical cancer is one of the major trends being witnessed in the . Cervical cancer is one of the most common cancers in women. Over 500,000 cases of cervical cancer were reported worldwide. In recent years, the weakened immune system has also been considered as one of the major factors associated with the increased risk of cervical cancer. However, several scientific achievements and new developments in the field of HPV vaccines have aided in the efficient screening of cervical cancer. This has further led to increased awareness worldwide. In addition, the use of cervical cancer diagnostics testing products and methods has increased.

This report is available at a USD 1,000 discount for a limited time only:

According to Technavio analysts, one of the key factors contributing to the growth of the global cervical cancer diagnostic testing market is increased adoption of HPV home testing kits:

Global cervical cancer diagnostic testing market: Increased adoption of HPV home testing kits

Market vendors have developed innovative home-based products that provide quick and accurate test results. This helps in reducing costs for patients and managing cervical cancer. The presence of such products in the market has enabled people to perform cervical cancer diagnostic testing. The increasing awareness of the benefits of the timely screening of cervical cancer and the adoption of home testing kits in developed and emerging economies is driving the market growth.

According to a senior analyst at Technavio for research on Oncology, “Breakspear medical offers the at-home HPV testing kit in the UK priced at $64.90, while an HPV test conducted in a laboratory cost around $300-$500. The cost-effectiveness of home screening kits has led to their increased adoption. The SoloPap test kit by SoloPap is awaiting FDA approval in the US. It can be potentially used for the early diagnosis of cervical cancer. Similarly, QIAGEN has developed the careHPV test, especially for countries that lack healthcare infrastructures such as laboratories and specialized clinics. This is expected to drive the market growth in the future.”

Global cervical cancer diagnostic testing market: Segmentation analysis

The global cervical cancer diagnostic testing market research report provides market segmentation by type (Pap smear test and HPV testing) and by region (the Americas, EMEA, and APAC). It provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges.

The Americas held the largest share of the market in 2018, accounting for close to 55% share. It was followed by EMEA and APAC respectively. The Americas will continue to lead the market due to the growing market demand for cervical cancer diagnostic testing products.

Looking for more information on this market?

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market ecosystem Market characteristics Market segmentation analysis

Market Sizing

Market definition Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Regional comparison Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

Vendors covered Vendor classification Market positioning of vendors Competitive scenario

About Technavio

is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at .

View source version on businesswire.com:https://www.businesswire.com/news/home/20181109005270/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES ONCOLOGY

SOURCE: Technavio Research

Copyright Business Wire 2018.

PUB: 11/09/2018 08:47 AM/DISC: 11/09/2018 08:46 AM

http://www.businesswire.com/news/home/20181109005270/en

AP RADIO
Update hourly